Realini et al.(3333 Realini T, Charlton J, Hettlinger M. The impact of anti-inflammatory therapy on intraocular pressure reduction following selective laser trabeculoplasty. Ophthalmic Surg Lasers Imaging. 2010;41(1):100-3.) 2009 |
25 |
OAG |
360° |
100 pulses of mean power per shot 0.9 mJ |
18.4±4.1
18.4±4.3
|
No treatment
Prednisolone 1%
|
1 drop 4 times daily for 7 days |
• IOP
• AC inflammation
|
Prospective, observer blinded, RCT |
Kahook(3232 ClinicalTrials.gov. Comparing acular LS and pred forte in reducing post-selective laser trabeculoplasty anterior chamber flare and cells [Internet]. Bethesda (MD): National Library of Medicine; 2000. [about 8 screens]. Available from: Comparing Acular LS and Pred Forte in Reducing Post-selective Laser Trabeculoplasty Anterior Chamber Flare and Cells - Full Text View - ClinicalTrials.gov) 2016 |
31 |
OAG |
No information |
No information |
17.8±4.5
17.0±3.3
16.1±3.1
|
Refresh Tears
Prednisolone 1%
Ketorolac 0.5%
|
1 drop 4 times daily for 4 days |
IOP |
Prospective, observer blinded RCT |
Champagne et al.(2828 Champagne S, Anctil JL, Goyette A, Lajoie C, Des Marchais B. Influence on intraocular pressure of anti-inflammatory treatments after selective laser trabeculoplasty. J Fr Ophtalmol. 2015; 38(7):588-94.) 2015 |
96 |
OAG |
180° |
50 pulses initially set at 0.7 mJ Total: Placebo: 43.60±2.01
Prednisolone: 45.20±1.86
Ketorolac: 48.04±1.82
|
25.01±0.47
25.86±0.69
25.85±0.70
|
Placebo
Prednisolone 1%
Diclofenac 0.1%
|
1 drop 4 times daily for 5 days |
• IOP
• Success of the SLT
• AC inflammation
|
Prospective, double blinded RCT |
De Keyser et al.(2929 De Keyser M, De Belder M, De Groot V. Randomized prospective study of the use of anti-inflammatory drops after selective laser trabeculoplasty. J Glaucoma. 2017;26(2):e22-e9.) 2017 |
132 |
• OAG
• NTG
• OHT
|
360° |
No treatment: 1.09
Dexamethasone 0.1%: 1.11±0.35
Indomethacin 0.1%: 1.07±0.30
|
-
22.02
23.98
|
No treatment
Dexamethasone 0.1%
Indomethacin 0.1%
|
1 drop 3 times daily for 7 days |
• IOP
• IOP Spike
• AC
• Inflammation
• Discomfort
• Effect on efficacy
|
Prospective RCT |
Growth et al.(3030 Groth SL, Albeiruti E, Nunez M, Fajardo R, Sharpsten L, Loewen N, et al. SALT Trial: steroids after laser trabeculoplasty: impact of short-term anti-inflammatory treatment on selective laser trabeculoplasty efficacy. Ophthalmology. 2019;126(11):1511-6. Comment in: Ophthalmology. 2020;127(2):e16-e17.) 2019 |
96 |
• OAG (75%)
• PXG (4%)
• Pigmentary (21%)
|
180° (36%)
270 (12%)
360° (52%)
|
50 to 100 pulses set at 0.8 mJ |
22.7±7
23.7±4.2
23.3±4.2
|
Placebo
Prednisolone 1%
Ketorolac 0.5%
|
1 drop 4 times daily for 5 days |
• IOP
• AC
• Inflammation
• Discomfort
|
Prospective, double blinded RCT |
Thrane et al.(3434 Thrane VR, Thrane AS, Bergo C, Halvorsen H, Krohn J. Effect of apraclonidine and diclofenac on early changes in intraocular pressure after selective laser trabeculoplasty. J Glaucoma. 2020; 29(4):280-6.) 2020 |
50 |
• OAG (24%)
• PXG (43%)
• NTG (24%)
• OHT (10%)
|
360° |
110 pulses set at 0.3 to 1.2 mJ |
17.3
19.3
17.2
|
Placebo
Apraclonidine 10mg/mL
Diclofenac 1mg/mL
|
1 drop 4 times daily for 5 days |
• IOP
• IOP Spike
• AC
• Inflammation
• Discomfort
|
Prospective, double blinded RCT |